Otsuka, Proteus to develop additional digital medicine systems

Proteus Digital Health Inc. (Redwood City, Calif.) and Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) expanded their collaboration to develop and commercialize additional digital medicines over the next five years. Otsuka paid Proteus $88 million in equity under the expanded deal.

The partners will jointly develop an expanded portfolio of digital medicines that combine therapeutics, such as atypical antipsychotics, with sensors. They will also develop next-generation product features and sensor capabilities...